PacificHealth Laboratories, Inc. (PHLI) is a nutrition technology company committed to research and development of dietary and nutritional supplements that can enhance health and well-being. The Company researches, develops and commercializes products for sports performance, weight loss and Type 2 diabetes that can be marketed without prior approval of the United States Food and Drug Administration, under current regulatory guidelines. The Company's sports performance products are Endurox, Endurox Excel, Endurox R4 Performance/Recovery Drink and Accelerade Sports Drink. Its weight loss products are Satietrol and Satietrol Complete. The Company has yet to launch a product for Type II diabetes. PHLI utilizes third-party contractors to manufacture all its products. During the year ended December 31, 2003, PHLI acquired Strong Research Corp., a research-based, educational sports nutrition company.